Metallohelices with activity against cisplatin-resistant cancer cells; Does the mechanism involve DNA binding?

Viktor Brabec, Suzanne E. Howson, Rebecca A. Kaner, Rianne M. Lord, Jaroslav Malina, Roger M. Phillips, Qasem M A Abdallah, Patrick C. McGowan, Alison Rodger, Peter Scott

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Enantiomers of a relatively rigid DNA-binding metallo-helix are shown to have comparable activity to that of cisplatin against the cell lines MCF7 (human breast adenocarcinoma) and A2780 (human ovarian carcinoma) but are ca five times more active against the cisplatin-resistant A2780cis. The cell-line HCT116 p53+/+ (human colon carcinoma) is highly sensitive giving IC 50 values in the nM range, far lower than the cisplatin control. The hypothesis that the biological target of such metallohelices is DNA is probed by various techniques. Tertiary structure changes in ct-DNA (formation of loops and intramolecular coiling) on exposure to the compounds are demonstrated by atomic force microscopy and supported by circular/linear dichroism in solution. Selectivity for 5′-CACATA and 5′-CACTAT segments is shown by DNase I footprinting. Various three- and four-way oligonucleotide junctions are stabilised, and remarkably only the Λ metallo-helix enantiomer stabilizes T-shaped 3WJs during gel electrophoresis; this is despite the lack of a known helix binding site. In studies with oligonucleotide duplexes with bulges it is also shown for the first time that the metallo-helix binding strength and the number of binding sites are dependent on the size of the bulge. In contrast to all the above, flexible metallo-helices show little propensity for structured or selective DNA binding, and while for A2780 the cancer cell line cytotoxicity is retained the A2780cis strain shows significant resistance. For all compounds in the study, H2AX FACS assays on HCT116 p53+/+ showed that no significant DNA damage occurs. In contrast, cell cycle analysis shows that the DNA binders arrest cells in the G2/mitosis phase, and while all compounds cause apoptosis, the DNA binders have the greater effect. Taken together these screening and mechanistic results are consistent with the more rigid helices acting via a DNA binding mechanism while the flexible assemblies do not.

Original languageEnglish
Pages (from-to)4407-4416
Number of pages10
JournalChemical Science
Volume4
Issue number12
Early online date10 Sep 2013
DOIs
Publication statusPublished - 1 Dec 2013
Externally publishedYes

Fingerprint

Cisplatin
Cells
DNA
Enantiomers
Oligonucleotides
Binders
Binding Sites
Deoxyribonuclease I
Cytotoxicity
Electrophoresis
Assays
Atomic force microscopy
Screening
Gels
Apoptosis

Cite this

Brabec, Viktor ; Howson, Suzanne E. ; Kaner, Rebecca A. ; Lord, Rianne M. ; Malina, Jaroslav ; Phillips, Roger M. ; Abdallah, Qasem M A ; McGowan, Patrick C. ; Rodger, Alison ; Scott, Peter. / Metallohelices with activity against cisplatin-resistant cancer cells; Does the mechanism involve DNA binding?. In: Chemical Science. 2013 ; Vol. 4, No. 12. pp. 4407-4416.
@article{af53db983f9d46d1a54ec969eed5de02,
title = "Metallohelices with activity against cisplatin-resistant cancer cells; Does the mechanism involve DNA binding?",
abstract = "Enantiomers of a relatively rigid DNA-binding metallo-helix are shown to have comparable activity to that of cisplatin against the cell lines MCF7 (human breast adenocarcinoma) and A2780 (human ovarian carcinoma) but are ca five times more active against the cisplatin-resistant A2780cis. The cell-line HCT116 p53+/+ (human colon carcinoma) is highly sensitive giving IC 50 values in the nM range, far lower than the cisplatin control. The hypothesis that the biological target of such metallohelices is DNA is probed by various techniques. Tertiary structure changes in ct-DNA (formation of loops and intramolecular coiling) on exposure to the compounds are demonstrated by atomic force microscopy and supported by circular/linear dichroism in solution. Selectivity for 5′-CACATA and 5′-CACTAT segments is shown by DNase I footprinting. Various three- and four-way oligonucleotide junctions are stabilised, and remarkably only the Λ metallo-helix enantiomer stabilizes T-shaped 3WJs during gel electrophoresis; this is despite the lack of a known helix binding site. In studies with oligonucleotide duplexes with bulges it is also shown for the first time that the metallo-helix binding strength and the number of binding sites are dependent on the size of the bulge. In contrast to all the above, flexible metallo-helices show little propensity for structured or selective DNA binding, and while for A2780 the cancer cell line cytotoxicity is retained the A2780cis strain shows significant resistance. For all compounds in the study, H2AX FACS assays on HCT116 p53+/+ showed that no significant DNA damage occurs. In contrast, cell cycle analysis shows that the DNA binders arrest cells in the G2/mitosis phase, and while all compounds cause apoptosis, the DNA binders have the greater effect. Taken together these screening and mechanistic results are consistent with the more rigid helices acting via a DNA binding mechanism while the flexible assemblies do not.",
author = "Viktor Brabec and Howson, {Suzanne E.} and Kaner, {Rebecca A.} and Lord, {Rianne M.} and Jaroslav Malina and Phillips, {Roger M.} and Abdallah, {Qasem M A} and McGowan, {Patrick C.} and Alison Rodger and Peter Scott",
year = "2013",
month = "12",
day = "1",
doi = "10.1039/c3sc51731d",
language = "English",
volume = "4",
pages = "4407--4416",
journal = "Chemical Science",
issn = "2041-6520",
publisher = "Royal Society of Chemistry",
number = "12",

}

Brabec, V, Howson, SE, Kaner, RA, Lord, RM, Malina, J, Phillips, RM, Abdallah, QMA, McGowan, PC, Rodger, A & Scott, P 2013, 'Metallohelices with activity against cisplatin-resistant cancer cells; Does the mechanism involve DNA binding?', Chemical Science, vol. 4, no. 12, pp. 4407-4416. https://doi.org/10.1039/c3sc51731d

Metallohelices with activity against cisplatin-resistant cancer cells; Does the mechanism involve DNA binding? / Brabec, Viktor; Howson, Suzanne E.; Kaner, Rebecca A.; Lord, Rianne M.; Malina, Jaroslav; Phillips, Roger M.; Abdallah, Qasem M A; McGowan, Patrick C.; Rodger, Alison; Scott, Peter.

In: Chemical Science, Vol. 4, No. 12, 01.12.2013, p. 4407-4416.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Metallohelices with activity against cisplatin-resistant cancer cells; Does the mechanism involve DNA binding?

AU - Brabec, Viktor

AU - Howson, Suzanne E.

AU - Kaner, Rebecca A.

AU - Lord, Rianne M.

AU - Malina, Jaroslav

AU - Phillips, Roger M.

AU - Abdallah, Qasem M A

AU - McGowan, Patrick C.

AU - Rodger, Alison

AU - Scott, Peter

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Enantiomers of a relatively rigid DNA-binding metallo-helix are shown to have comparable activity to that of cisplatin against the cell lines MCF7 (human breast adenocarcinoma) and A2780 (human ovarian carcinoma) but are ca five times more active against the cisplatin-resistant A2780cis. The cell-line HCT116 p53+/+ (human colon carcinoma) is highly sensitive giving IC 50 values in the nM range, far lower than the cisplatin control. The hypothesis that the biological target of such metallohelices is DNA is probed by various techniques. Tertiary structure changes in ct-DNA (formation of loops and intramolecular coiling) on exposure to the compounds are demonstrated by atomic force microscopy and supported by circular/linear dichroism in solution. Selectivity for 5′-CACATA and 5′-CACTAT segments is shown by DNase I footprinting. Various three- and four-way oligonucleotide junctions are stabilised, and remarkably only the Λ metallo-helix enantiomer stabilizes T-shaped 3WJs during gel electrophoresis; this is despite the lack of a known helix binding site. In studies with oligonucleotide duplexes with bulges it is also shown for the first time that the metallo-helix binding strength and the number of binding sites are dependent on the size of the bulge. In contrast to all the above, flexible metallo-helices show little propensity for structured or selective DNA binding, and while for A2780 the cancer cell line cytotoxicity is retained the A2780cis strain shows significant resistance. For all compounds in the study, H2AX FACS assays on HCT116 p53+/+ showed that no significant DNA damage occurs. In contrast, cell cycle analysis shows that the DNA binders arrest cells in the G2/mitosis phase, and while all compounds cause apoptosis, the DNA binders have the greater effect. Taken together these screening and mechanistic results are consistent with the more rigid helices acting via a DNA binding mechanism while the flexible assemblies do not.

AB - Enantiomers of a relatively rigid DNA-binding metallo-helix are shown to have comparable activity to that of cisplatin against the cell lines MCF7 (human breast adenocarcinoma) and A2780 (human ovarian carcinoma) but are ca five times more active against the cisplatin-resistant A2780cis. The cell-line HCT116 p53+/+ (human colon carcinoma) is highly sensitive giving IC 50 values in the nM range, far lower than the cisplatin control. The hypothesis that the biological target of such metallohelices is DNA is probed by various techniques. Tertiary structure changes in ct-DNA (formation of loops and intramolecular coiling) on exposure to the compounds are demonstrated by atomic force microscopy and supported by circular/linear dichroism in solution. Selectivity for 5′-CACATA and 5′-CACTAT segments is shown by DNase I footprinting. Various three- and four-way oligonucleotide junctions are stabilised, and remarkably only the Λ metallo-helix enantiomer stabilizes T-shaped 3WJs during gel electrophoresis; this is despite the lack of a known helix binding site. In studies with oligonucleotide duplexes with bulges it is also shown for the first time that the metallo-helix binding strength and the number of binding sites are dependent on the size of the bulge. In contrast to all the above, flexible metallo-helices show little propensity for structured or selective DNA binding, and while for A2780 the cancer cell line cytotoxicity is retained the A2780cis strain shows significant resistance. For all compounds in the study, H2AX FACS assays on HCT116 p53+/+ showed that no significant DNA damage occurs. In contrast, cell cycle analysis shows that the DNA binders arrest cells in the G2/mitosis phase, and while all compounds cause apoptosis, the DNA binders have the greater effect. Taken together these screening and mechanistic results are consistent with the more rigid helices acting via a DNA binding mechanism while the flexible assemblies do not.

UR - http://www.scopus.com/inward/record.url?scp=84886810902&partnerID=8YFLogxK

UR - http://pubs.rsc.org/en/journals/journalissues/sc#!recentarticles&adv

U2 - 10.1039/c3sc51731d

DO - 10.1039/c3sc51731d

M3 - Article

VL - 4

SP - 4407

EP - 4416

JO - Chemical Science

JF - Chemical Science

SN - 2041-6520

IS - 12

ER -